:::
  • 20261124-1
  • Lectures
  • Institute of Biomedical Sciences
  • Location

    B1B Lecture Room, IBMS

  • Speaker Name

    Dr. Kenta Nakamura (UW, Seattle)

  • State

    Definitive

  • Url
Cardiac regenerative therapy: Cell-based remuscularization and gene-based angiogenesis

2026-11-24 11:00 - 12:00

Add To Calendar

Our research focuses on gene- and cell-based therapies to solve the most difficult challenges in heart disease, specifically targeting two main areas:

  • Cell Therapy for Heart Repair: We propose transplantation of stem cell-derived cardiomyocytes to treat heart attacks and heart failure. Transplant-induced (engraftment) arrhythmias and immune rejection are significant barriers to clinical translation. Through multi-disciplinary collaboration across in silico, in vitro and in vivo platforms, we have developed specific dosing and medication strategies to mitigate arrhythmia risk and developed a framework to safely manage stem cell transplants.
  • Gene Therapy for Refractory Angina: Patients with advanced atherosclerosis suffer from constant chest pain (refractory angina) due to inadequate coronary perfusion despite maximal medical therapy and surgical and percutaneous revisualization. We propose that viral transduction of growth factors to stimulate endogenesis angiogenesis may improve perfusion and symptoms for these “no option” patients. Our early phase trial showed a strong safety profile and promising preliminary efficacy, leading to an ongoing international randomized control trial.